OneSource Specialty Pharma Limited (BOM:544292)
India flag India · Delayed Price · Currency is INR
1,652.60
+60.85 (3.82%)
At close: May 13, 2025

BOM:544292 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023
Period Ending
Mar '25 Mar '24 Mar '23
Revenue
14,4491,719387.14
Revenue Growth (YoY)
740.43%344.07%-
Cost of Revenue
4,350852.13336.43
Gross Profit
10,098867.0650.71
Selling, General & Admin
2,153825.5749.29
Other Operating Expenses
3,280844.61808.7
Operating Expenses
8,1722,4332,215
Operating Income
1,926-1,566-2,164
Interest Expense
-1,663-853.99-401.06
Interest & Investment Income
-17.6514.67
Currency Exchange Gain (Loss)
--5.75-91.59
Other Non Operating Income (Expenses)
174.74-38.97-73.21
EBT Excluding Unusual Items
437.79-2,447-2,715
Merger & Restructuring Charges
-1,108--
Gain (Loss) on Sale of Investments
-7.571.15
Gain (Loss) on Sale of Assets
--58.08-
Asset Writedown
--1,159-1,451
Pretax Income
-670.66-3,657-4,156
Income Tax Expense
-497.85--
Earnings From Continuing Operations
-172.81-3,657-4,156
Earnings From Discontinued Operations
-6.9-254.68-3,842
Net Income
-179.71-3,912-7,998
Net Income to Common
-179.71-3,912-7,998
Shares Outstanding (Basic)
1104240
Shares Outstanding (Diluted)
1104240
Shares Change (YoY)
165.37%4.34%-
EPS (Basic)
-1.63-94.15-200.87
EPS (Diluted)
-1.63-94.15-200.87
Free Cash Flow
-1,960-1,710-2,068
Free Cash Flow Per Share
-17.78-41.15-51.93
Gross Margin
69.89%50.43%13.10%
Operating Margin
13.33%-91.09%-558.99%
Profit Margin
-1.24%-227.53%-2066.00%
Free Cash Flow Margin
-13.57%-99.45%-534.07%
EBITDA
4,665-803.03-1,507
EBITDA Margin
32.29%-46.71%-
D&A For EBITDA
2,739762.95656.8
EBIT
1,926-1,566-2,164
EBIT Margin
13.33%-91.09%-
Revenue as Reported
14,6231,761414.06
Advertising Expenses
-5.0410.44
Source: S&P Global Market Intelligence. Standard template. Financial Sources.